Concepedia

Vatana Long

VL

4

Publications

320

Citations

4

H-Index

2008

Active since

Affiliations

MacroGenics (United States)(Current)

Vatana Long is an author at MacroGenics (United States) specializing in immunology, autoimmune disease, and medicine.

Top concepts

Publications per year

2008–2018

4

Publications

4

BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact

Jean L. Scholz, Jenni E. Crowley, Mary M. Tomayko et al. · Proceedings of the National Academy of Sciences · 2008 · 170 citations · Full text

, , +17

Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer

Paul A. Moore, Kalpana Shah, Yinhua Yang et al. · Molecular Cancer Therapeutics · 2018 · 71 citations

MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies

Liqin Liu, Chia‐Ying K. Lam, Vatana Long et al. · Clinical Cancer Research · 2016 · 68 citations · Full text

MGD011, Humanized CD19 x CD3 DART® Protein with Enhanced Pharmacokinetic Properties, Demonstrates Potent T-Cell Mediated Anti-Tumor Activity in Preclinical Models and Durable B-Cell Depletion in Cynomolgus Monkeys Following Once-a-Week Dosing

Liqin Liu, Annie Lam, Ralph Alderson et al. · Blood · 2014 · 11 citations

Rows per page

1–4 of 4